Possible role of lymphocyte cytotoxicity in bone-marrow grafting.
D000741:Anemia, Aplastic / Q000628:therapy; D000961:Antilymphocyte Serum / Q000627:therapeutic use; D001803:Blood Transfusion; D001854:Bone Marrow Cells; D016026:Bone Marrow Transplantation; D002860:Chromium Radioisotopes; D003520:Cyclophosphamide / Q000627:therapeutic use; D003601:Cytotoxicity Tests, Immunologic; D005260:Female; D006084:Graft Rejection; D006650:Histocompatibility Testing; D006801:Humans; D007165:Immunosuppression Therapy; D007945:Leukemia, Lymphoid / Q000628:therapy; D007959:Lymphocyte Culture Test, Mixed; D008214:Lymphocytes / Q000276:immunology*
D000961:Antilymphocyte Serum; D002860:Chromium Radioisotopes; D003520:Cyclophosphamide